Status | Study |
Enrolling by invitation |
Study Name: Study to Assess the Long Term Safety and Efficacy of UX007 in Subjects With Glucose Type 1 DS Condition: Glucose Transporter Type 1 Deficiency Syndrome Date: 2015-11-03 Interventions: Drug: UX007 UX007 is a liquid intended for oral (PO) administration. |
Recruiting |
Study Name: Glycosade v UCCS in the Dietary Management of Hepatic GSD Condition: Glycogen Storage Disease Date: 2014-12-12 Interventions: Dietary Supplement: Medical Food - Glycosade double blind randomised crossover of 2 starches - glycosade |
Recruiting |
Study Name: The Effect of Triheptanoin in Adults With McArdle Disease (Glycogen Storage Disease Type V) Condition: Glycogen Storage Disease Type V Date: 2014-11-04 Interventions: Drug: Triheptanoin Anaplerotic |
Completed |
Study Name: Study of Glycogen Storage Disease Expression in Carriers Condition: Glycogen Storage Disease Date: 2014-02-05 Interventions: Genetic: Glycogen Storage Disease markers Blood and urine tests will be performed on all groups to measu |
Completed |
Study Name: Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch Condition: Glycogen Storage Disease Type IA Glycogen Storage Disease Type IB Date: 2014-01-31 Interventions: Dietary Supplement: Glycosade |
Recruiting |
Study Name: An Open-Label Trial of Triheptanoin in Patients With Glucose Transporter Type-1 Deficiency Syndrome Condition: Glucose Transporter Type-1 Deficiency Syndrome (Glut1 DS) Date: 2014-01-13 Interventions: Drug: Triheptanoin Schedule A: Subjects previously treated |
Not yet recruiting |
Study Name: Triheptanoin (C7 Oil), a Food Supplement, for Glucose Transporter Type I Deficiency (G1D) Condition: Glucose Transporter Type 1 Deficiency Syndrome Glut1 Deficiency Syndrome Date: 2013-12-12 Interventions: Drug: Triheptanoin Triheptanoin (C7 oil) is a 7-carbon medium chain triglyceride. |
Not yet recruiting |
Study Name: Treatment Development for Glucose Transporter Type I Deficiency Syndrome (G1D) Condition: Glucose Transporter Type 1 Deficiency Syndrome GLUT1 Deficiency Syndrome Date: 2013-12-11 Interventions: Drug: Triheptanoin Triheptanoin is a 7-carbon medium chain triglyceride |
Available |
Study Name: Post Study Continuation of C7 for G1D Condition: Glut1 Deficiency Syndrome Glucose Transporter Type 1 Deficiency Syndrome Date: 2013-12-11 Interventions: Drug: Triheptanoin Other Names: C7 oil Heptanoate hep |
Recruiting |
Study Name: The Glucose Transporter Type I Deficiency (G1D) Registry Condition: GLUT1 Deficiency Syndrome Glucose Transporter Type 1 Deficiency Syndrome Date: 2013-12-11 Interventions: Other: No intervention This is an observational registry. No interventions are required or provided. |